Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation.
Handley G, Yepes A, Eliassen E, Dominguez G, Pasikhova Y, Klinkova O, Baluch A, Febres-Aldana AJ, Alsina M, Elmariah H, Khimani F, Hansen DK, Freeman CL, Jain MD, Locke F, Lazaryan A, Liu HD, Mishra A, Mirza AS, Nishihori T, Ochoa L, Perez L, Pidala J, Puglianini OC, Nieder M, Perna F, Kim J, Bejanyan N, Faramand R. Handley G, et al. Among authors: nieder m. Open Forum Infect Dis. 2024 Sep 26;11(10):ofae564. doi: 10.1093/ofid/ofae564. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39411216 Free PMC article.
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Elmariah H, Otoukesh S, Kumar A, Ali H, Arslan S, Shouse G, Pourhassan H, Nishihori T, Faramand R, Mishra A, Khimani F, Fernandez H, Lazaryan A, Nieder M, Perez L, Liu H, Nakamura R, Pidala J, Marcucci G, Forman SJ, Anasetti C, Locke F, Bejanyan N, Al Malki MM. Elmariah H, et al. Among authors: nieder m. Transplant Cell Ther. 2024 Feb;30(2):229.e1-229.e11. doi: 10.1016/j.jtct.2023.11.010. Epub 2023 Nov 11. Transplant Cell Ther. 2024. PMID: 37952648 Clinical Trial.
Mismatched donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations.
Caprice T, Fan W, Kim J, Faramand R, Mishra A, Perez L, Khimani F, Lazaryan A, Ochoa-Bayona JL, Liu H, Jain MD, Nieder M, Anasetti C, Nishihori T, Pidala JA, Bejanyan N, Elmariah H. Caprice T, et al. Among authors: nieder m. Am J Hematol. 2024 Jun;99(6):1196-1200. doi: 10.1002/ajh.27305. Epub 2024 Mar 28. Am J Hematol. 2024. PMID: 38546371 No abstract available.
Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide.
Elmariah H, Otoukesh S, Kumar A, Haris Ali, Shukaib Arslan, Dimaggio E, Gonzalez R, Shouse G, Pourhassan H, Taiga Nishihori, Faramand R, Mishra A, Khimani F, Fernandez H, Lazaryan A, Nieder M, Perez L, Liu H, Ryotaro Nakamura, Pidala J, Guido Marcucci, Stephen J Forman, Anasetti C, Bejanyan N, Monzr M Al Malki. Elmariah H, et al. Among authors: nieder m. Transplant Cell Ther. 2024 Oct;30(10):1019.e1-1019.e9. doi: 10.1016/j.jtct.2024.07.024. Epub 2024 Aug 3. Transplant Cell Ther. 2024. PMID: 39102983
Melphalan Dose in Combination With Fludarabine Affects Gastrointestinal Toxicity and Graft-Versus-Host Disease After Allogeneic Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Albanyan O, Elmariah H, Kalos D, Kim J, Faramand R, Sallman D, Mishra A, Sweet K, Perez L, Ochoa-Bayona J, Nieder M, Komrokji R, Lancet J, Fernandez H, Nishihori T, Pidala J, Anasetti C, Bejanyan N. Albanyan O, et al. Among authors: nieder m. Transplant Cell Ther. 2024 Nov;30(11):1090.e1-1090.e10. doi: 10.1016/j.jtct.2024.08.007. Epub 2024 Aug 13. Transplant Cell Ther. 2024. PMID: 39147136
Feasibility and Toxicity of Full-Body Volumetric Modulated Arc Therapy Technique for High-Dose Total Body Irradiation.
Keit E, Liveringhouse C, Figura N, Weygand J, Sandoval ML, Garcia G, Peters J, Nieder M, Faramand R, Khimani F, Kim S, Robinson TJ, Johnstone PAS, Penagaricano J, Latifi K. Keit E, et al. Among authors: nieder m. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231180779. doi: 10.1177/15330338231180779. Technol Cancer Res Treat. 2023. PMID: 37287260 Free PMC article.
Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group.
Otto WR, Dvorak CC, Boge CLK, Ostrosky-Zeichner L, Esbenshade AJ, Nieder ML, Alexander S, Steinbach WJ, Dang H, Villaluna D, Chen L, Skeens M, Zaoutis TE, Sung L, Fisher BT. Otto WR, et al. Among authors: nieder ml. Pediatr Transplant. 2023 Feb;27(1):e14399. doi: 10.1111/petr.14399. Epub 2022 Oct 26. Pediatr Transplant. 2023. PMID: 36299233 Free PMC article.
Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation.
Mirza AS, Tandon A, Jenneman D, Cao S, Brimer T, Kumar A, Kidd M, Khimani F, Faramand R, Mishra A, Liu H, Nishihori T, Perez L, Lazaryan A, Bejanyan N, Nieder M, Anasetti C, Pidala J, Elmariah H. Mirza AS, et al. Among authors: nieder m. Transplant Cell Ther. 2022 Apr;28(4):185.e1-185.e7. doi: 10.1016/j.jtct.2022.01.003. Epub 2022 Jan 10. Transplant Cell Ther. 2022. PMID: 35017119 Free article.
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease.
Lazaryan A, Lee S, Arora M, Kim J, Betts BC, Khimani F, Nishihori T, Bejanyan N, Liu H, Kharfan-Dabaja MA, Locke FL, Gonzalez R, Jain MD, Davila ML, Perez LE, Mishra A, Perez Perez A, Balke K, Ayala E, Ochoa L, Castaneda Puglianini O, Faramand R, Alsina M, Elmariah H, Nieder ML, Fernandez H, Anasetti C, Pidala JA. Lazaryan A, et al. Among authors: nieder ml. Blood Adv. 2022 Jan 11;6(1):259-269. doi: 10.1182/bloodadvances.2021005552. Blood Adv. 2022. PMID: 34649279 Free PMC article. Clinical Trial.
108 results